30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

A Final Look at 2010 Results: BioMimetic Therapeutics

Augment Bone Graft
* ~650 patients enrolled in Augment clinical trials over 4 years
* FDA orthopaedic advisory panel meeting confirmed for 5/11 to review premarket approval application
I* n Canada, transitioning from single exclusive distributor to network of >30 independent agents covering whole country
* Presented preclinical study results demonstrating beneficial effects of technology on cartilage and bone repair in knee, effectiveness of rhPDGF-BB intra-tendon delivery for tendon repair
* Announced results of preclinical study of interbody lumbar fusion in 2-level ovine model: Augment-treated specimens demonstrated highest fusion scores, showed equivalency to autograft